89bio: Pegozafermin Could Be A Game-Changer For Liver Disease – Strong Buy (NASDAQ:ETNB)
mi-viri 89bio, Inc. (NASDAQ:ETNB) is a clinical-stage biopharmaceutical company based in San Francisco, California. The company focuses on developing therapies...
